Patents by Inventor James Allen CARDELLI

James Allen CARDELLI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11096952
    Abstract: A method of treating an activated fibroblast associated disease or pre-disease condition in a mammal comprising, administering a pharmaceutical composition including a therapeutically effective amount of a first therapeutic, wherein the first therapeutic is one of an intracellular Ca2+ elevator, a YAP/TAZ inhibitor, both a intracellular Ca2+ elevator and a YAP/TAZ inhibitor, or pharmacologically acceptable salts, solvates, esters, amides, clathrates, stereoisomers, enantiomers, prodrugs or analogs thereof, or a combination thereof.
    Type: Grant
    Filed: February 2, 2017
    Date of Patent: August 24, 2021
    Assignee: BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE
    Inventors: James Allen Cardelli, Charles Albert Stephens, Alana Lea Gray, David Thomas Coleman
  • Patent number: 10959968
    Abstract: A method of treating cancer or a precancer condition in a mammal comprising administering a therapeutically effective amount of a homovanillyl sinapate analog or pharmacologically acceptable salt, solvate, ester, amide, clathrate, stereoisomer, enantiomer, prodrug or analog thereof, or a combination thereof.
    Type: Grant
    Filed: January 13, 2017
    Date of Patent: March 30, 2021
    Assignee: BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY
    Inventors: James Allen Cardelli, Ana-Maria Dragoi, Khalid El-Sayed, Mohamed M. Mohyeldin
  • Publication number: 20200330447
    Abstract: Methods and compositions for treating a lysosomal movement associated disease in an animal, in which the position of lysosomes can influence disease progression, comprising administering an effective amount of a first lysosome migration inhibitor or a pharmaceutically acceptable salt, solvate, clathrate, stereoisomer, enantiomer or prodrug thereof.
    Type: Application
    Filed: June 29, 2020
    Publication date: October 22, 2020
    Inventors: James Allen CARDELLI, Magdalena Liliana CIRCU, Samantha Sarah DYKES, Hazem Edmond EL-OSTA
  • Patent number: 10695338
    Abstract: Methods and compositions for treating a lysosomal movement associated disease in an animal, in which the position of lysosomes can influence disease progression, comprising administering an effective amount of a first lysosome migration inhibitor or a pharmaceutically acceptable salt, solvate, clathrate, stereoisomer, enantiomer or prodrug thereof.
    Type: Grant
    Filed: May 6, 2016
    Date of Patent: June 30, 2020
    Assignee: Board of Supervisors of Louisiana State University and Agricultural and Mechanical College
    Inventors: James Allen Cardelli, Magdalena Liliana Circu, Samantha Sarah Dykes, Hazem Edmond El-Osta
  • Publication number: 20190328690
    Abstract: A method of treating cancer or a precancer condition in a mammal comprising administering a therapeutically effective amount of a homovanillyl sinapate analog or pharmacologically acceptable salt, solvate, ester, amide, clathrate, stereoisomer, enantiomer, prodrug or analog thereof, or a combination thereof.
    Type: Application
    Filed: January 13, 2017
    Publication date: October 31, 2019
    Inventors: James Allen CARDELLI, Ana-Maria DRAGOI, Khalid EL-SAYED, Mohamed M. MOHYELDIN
  • Publication number: 20190038655
    Abstract: A method of treating an activated fibroblast associated disease or pre-disease condition in a mammal comprising, administering a pharmaceutical composition including a therapeutically effective amount of a first therapeutic, wherein the first therapeutic is one of an intracellular Ca2+ elevator, a YAP/TAZ inhibitor, both a intracellular Ca2+ elevator and a YAP/TAZ inhibitor, or pharmacologically acceptable salts, solvates, esters, amides, clathrates, stereoisomers, enantiomers, prodrugs or analogs thereof, or a combination thereof.
    Type: Application
    Filed: February 2, 2017
    Publication date: February 7, 2019
    Inventors: James Allen CARDELLI, Charles Albert STEPHENS, Alana Lea GRAY, David Thomas COLEMAN
  • Publication number: 20180133208
    Abstract: Methods and compositions for treating a lysosomal movement associated disease in an animal, in which the position of lysosomes can influence disease progression, comprising administering an effective amount of a first lysosome migration inhibitor or a pharmaceutically acceptable salt, solvate, clathrate, stereoisomer, enantiomer or prodrug thereof.
    Type: Application
    Filed: May 6, 2016
    Publication date: May 17, 2018
    Applicant: Board of Supervisors of Louisiana State University and Agricultural and Mechanical College
    Inventors: James Allen CARDELLI, Magdalena Liliana CIRCU, Samantha Sarah DYKES, Hazem Edmond EL-OSTA
  • Publication number: 20180085415
    Abstract: Products and methods of treating a foam cell associated disease comprising administering a pharmaceutical composition including a therapeutically effective amount of a first therapeutic; wherein the first therapeutic is one of an extract of Artemisia dracunculus (Russian Tarragon) leaves, an extract of Melia azedarach (Chinaberry) leaves, an extract of Saururus cernuus (Lizard's Tail) Roots, and an extract of Sambucus Canadensis (Elderberry) leaves, or pharmacologically acceptable salts, solvates, esters, amides, clathrates, stereoisomers, enantiomers, prodrugs or analogs thereof, or a combination thereof.
    Type: Application
    Filed: September 22, 2017
    Publication date: March 29, 2018
    Inventors: James Allen CARDELLI, Matthew Dale WOOLARD